» DEA
DEA and SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications until November 2023 while Considering Public Comments
June 2nd, 2023
The Drug Enforcement Administration (DEA) jointly with the Substance Abuse and Mental Health Services Administration (SAMHSA) published a temporary rule, effective May 11, 2023, extending flexibilities for the prescribing of controlled substances thr…
Read More
Read More
Categories: Client Advisory
